Ernexa Therapeutics stock surges 30% on preclinical data

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Intensity Therapeutics resumes patient dosing in Swiss trial Hisse Senetleri 0 1
A Ra Capital Management funds buy $194k in Artiva Biotherapeutics stock Hisse Senetleri 0 1
A Form 4 Artiva Biotherapeutics Inc For: 14 July Hisse Senetleri 0 2
A Form 4 United Therapeutics Corporation For: 14 July Hisse Senetleri 0 1
A Bicara Therapeutics CEO Claire Mazumdar disposes of $284k in stock Hisse Senetleri 0 1
A Form 144 Kymera Therapeutics For: 13 July Hisse Senetleri 0 3
A Form 8K Ernexa Therapeutics Inc For: 20 March Hisse Senetleri 0 35
A Ernexa therapeutics ten percent owner Cherington buys $2m in stock Hisse Senetleri 0 22

Benzer konular

Üst